Organon/OGN

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Organon

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Ticker

OGN

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Jersey City, United States

Employees

10,000

Organon Metrics

BasicAdvanced
$5.2B
Market cap
4.93
P/E ratio
$4.08
EPS
0.77
Beta
$1.12
Dividend rate
5.57%
Dividend yield
$5.2B
0.77
$1.12
1.649
0.837
18,135.417
18,154.167
27.79%
2.56%
7.44%
-303.92%
4.93
0.81
107.31
-0.98
11.23
5.57%
3.29%
39.65%
0.47%
-17.72%

What the Analysts think about Organon

Analyst Ratings

Majority rating from 10 analysts.
Hold

Organon Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
12.39% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.6B
1.50%
Net income
$201M
-63.19%
Profit margin
12.39%
-63.73%

Organon Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 25.69%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.31
$0.87
$0.88
$1.22
-
Expected
$1.01
$1.06
$0.83
$0.97
$1.17
Surprise
30.13%
-17.66%
6.02%
25.69%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Organon stock?

Organon (OGN) has a market cap of $5.2B as of July 04, 2024.

What is the P/E ratio for Organon stock?

The price to earnings (P/E) ratio for Organon (OGN) stock is 4.93 as of July 04, 2024.

Does Organon stock pay dividends?

Yes, the Organon (OGN) stock pays dividends to shareholders. As of July 04, 2024, the dividend rate is $1.12 and the yield is 5.57%. Organon has a payout ratio of 27.79% on a trailing twelve-month basis.

When is the next Organon dividend payment date?

The next Organon (OGN) dividend payment date is unconfirmed.

What is the beta indicator for Organon?

Organon (OGN) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Organon stock

Buy or sell Organon stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing